Daiwa Securities Group »

Lexeo Therapeutics shares owned by Daiwa Securities Group

Quarter-by-quarter ownership of Lexeo Therapeutics (LXEO) shares owned by Daiwa Securities Group from 13F filings

Historical chart of Daiwa Securities Group investment in Lexeo Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Lexeo Therapeutics held by Daiwa Securities Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lexeo Therapeutics by Daiwa Securities Group

Quarter filed Position value Share count Share price at filing
2025-12-31 $2.0k 243 8.23

More positions owned by Daiwa Securities Group

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Meta Platforms Cl A (META)
Welltower Inc Com reit (WELL)
Palantir Technologies Cl A (PLTR)
Netflix (NFLX)
Crowdstrike Hldgs Cl A (CRWD)
Digital Realty Trust (DLR)
Prologis (PLD)
Alphabet Cap Stk Cl C Put Option (GOOG)
Crown Castle Intl (CCI)

View all positions for Daiwa Securities Group

Top funds holding Lexeo Therapeutics

Henderson Group
BlackRock
Paradigm Biocapital Advisors
Vestal Point Capital
Frazier Life Sciences Management
Balyasny Asset Management
Vanguard Group
Citadel Advisors
venBio Select Advisor
Affinity Asset Advisors
Woodline Partners
State Street Corporation
Millennium Management
OrbiMed Advisors
Point72 Asset Management

View all funds holding Lexeo Therapeutics